Patents by Inventor José Alberto GARCÍA SANZ

José Alberto GARCÍA SANZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody for the diagnosis, treatment and/or prevention of brain tumors and brain lesions
    Patent number: 10401363
    Abstract: The invention relates to the use of the monoclonal antibody NILO1 for the diagnosis, treatment and/or prevention of brain tumors and lesions. Particularly, the invention relates to methods for the diagnosis of brain tumors and brain lesions in which cells marked with said antibody, or with immunologically active fragments thereof, are detected. The invention also relates to the use of said monoclonal antibody, or immunologically active fragments thereof, as a medicament for the treatment and/or prevention of brain tumors and brain lesions. In a preferred embodiment of the invention, the monoclonal antibody NILO1, or its immunologically active fragments, are humanized.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: September 3, 2019
    Assignees: ALTHIA HEALTH, S.L., CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
    Inventors: Augusto Silva González, José Alberto García Sanz
  • Antibodies against CCR9 and methods of use thereof
    Patent number: 9884915
    Abstract: The present invention relates to antibodies binding specifically to CCR9, and to antigen-binding fragments thereof. It also relates to uses thereof and diagnostic methods using said antibodies.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: February 6, 2018
    Assignee: Consejo Superior de Investigaciones Cientificas C.S.I.C.
    Inventors: Sonia Chamorro Pérez, Ana Franco Villanueva, José Alberto García Sanz, Leonor Kremer Barón, Carlos Martínez Alonso, Maria Vela Cuenca, Laura Carramolino Fitera
  • MONOCLONAL ANTIBODY FOR THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF BRAIN TUMORS AND BRAIN LESIONS
    Publication number: 20180011095
    Abstract: The invention relates to the use of the monoclonal antibody NILO1 for the diagnosis, treatment and/or prevention of brain tumors and lesions. Particularly, the invention relates to methods for the diagnosis of brain tumors and brain lesions in which cells marked with said antibody, or with immunologically active fragments thereof, are detected. The invention also relates to the use of said monoclonal antibody, or immunologically active fragments thereof, as a medicament for the treatment and/or prevention of brain tumors and brain lesions. In a preferred embodiment of the invention, the monoclonal antibody NILO1, or its immunologically active fragments, are humanized.
    Type: Application
    Filed: December 17, 2015
    Publication date: January 11, 2018
    Inventors: Augusto SILVA GONZÁLEZ, José Alberto GARCÍA SANZ
  • ANTIBODIES AGAINST CCR9 AND APPLICATIONS THEREOF
    Publication number: 20160257756
    Abstract: The present invention relates to antibodies binding specifically to CCR9, and to antigen-binding fragments thereof. It also relates to uses thereof and diagnostic methods using said antibodies.
    Type: Application
    Filed: November 25, 2014
    Publication date: September 8, 2016
    Inventors: Sonia CHAMORRO PÉREZ, Ana FRANCO VILLANUEVA, José Alberto GARCÍA SANZ, Leonor KREMER BARÓN, Carlos MARTÍNEZ ALONSO, María VELA CUENCA, Laura CARRAMOLINO FITERA